Intellia Therapeutics NTLA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's operating lease liabilities?
- Intellia Therapeutics (NTLA) reported operating lease liabilities of $61.4M in Q1 2026.
- How has Intellia Therapeutics's operating lease liabilities changed year-over-year?
- Intellia Therapeutics's operating lease liabilities decreased by 23.7% year-over-year, from $80.49M to $61.4M.
- What is the long-term trend for Intellia Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), Intellia Therapeutics's operating lease liabilities has grown at a 14.7% compound annual growth rate (CAGR), from $33.61M to $66.85M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.